Alvotech (ALVO) Price Target Analysis
Updated Jun 26, 2026
Analyst Rating: Buy
Based on 5 analysts133.7% Below Target
ALVO trades 133.7% below Wall Street's consensus target of $8.60.
Current Price$3.68
Average Target$8.60
Target
Current
Low$5.00
Median$10.00
High$10.00
Analyst Target Range
Forward P/E66.2x
(High Premium)
PEG Ratio—
Implied Growth+122.7%
(High Growth)
Analyst Spread58.1%
(Moderate)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes ALVO achieves its forward estimates and maintains a stable P/E multiple of 66.2x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
ALVO Price Target Analysis
Updated June 29, 2026As of June 29, 2026, Alvotech (ALVO) has a Wall Street consensus price target of $8.60, based on estimates from 5 covering analysts. With the stock currently trading at $3.68, this represents a potential upside of +133.7%. The company has a market capitalization of $1.23B.
Analyst price targets range from a low of $5.00 to a high of $10.00, representing a 58% spread in expectations. The median target of $10.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, ALVO trades at a trailing P/E of 36.8x and forward P/E of 66.2x. Analysts expect EPS to grow +122.7% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+10.3%
Industry Consensus
Avg Forward P/E
15.6x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AMGNAmgen Inc. | $193.4B | $358.33 | $349.33 | -2.5% | Buy | 16.0x | 38 |
 TEVATeva Pharmaceutical Industries Limited | $38.7B | $33.21 | $40.00 | +20.4% | Buy | 15.2x | 46 |
 VTRSViatris Inc. | $19.0B | $16.33 | $17.40 | +6.6% | Hold | 6.6x | 13 |
 ABBVAbbVie Inc. | $444.4B | $251.52 | $258.00 | +2.6% | Buy | 17.7x | 41 |
 JNJJohnson & Johnson | $613.0B | $254.66 | $253.42 | -0.5% | Buy | 22.0x | 40 |
 PFEPfizer Inc. | $138.1B | $24.29 | $26.75 | +10.2% | Hold | 8.2x | 39 |
 BIIBBiogen Inc. | $31.9B | $216.03 | $218.32 | +1.1% | Buy | 14.9x | 48 |
 REGNRegeneron Pharmaceuticals, Inc. | $65.8B | $632.90 | $836.00 | +32.1% | Buy | 13.6x | 48 |
 MRKMerck & Co., Inc. | $317.1B | $128.38 | $131.58 | +2.5% | Buy | 25.0x | 37 |
 MCKMcKesson Corporation | $91.8B | $763.51 | $994.86 | +30.3% | Buy | 17.3x | 31 |
ALVO — Frequently Asked Questions
Quick answers to the most common questions about buying ALVO stock.
What is the ALVO stock price target for 2026?
The consensus Wall Street price target for ALVO is $8.6, representing 133.7% upside from the current price of $3.68. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is ALVO a buy, sell, or hold?
ALVO has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $8.6 implies 133.7% upside from current levels.
Is ALVO stock overvalued or undervalued?
At a forward P/E of 66.1871x, ALVO trades at a premium valuation. The consensus price target of $8.6 (133.7% upside) suggests analysts still see growth justifying the multiple.
How high can ALVO stock go?
The most bullish Wall Street analyst has a price target of $10 for ALVO, while the most conservative target is $5. The consensus of $8.6 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover ALVO stock?
ALVO is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ALVO stock forecast?
The 12-month ALVO stock forecast based on 5 Wall Street analysts shows a consensus price target of $8.6, with estimates ranging from $5 (bear case) to $10 (bull case). The median consensus rating is "Buy".
What is ALVO's forward P/E ratio?
ALVO trades at a forward P/E ratio of 66.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 36.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ALVO stock?
Wall Street analysts are very optimistic on ALVO, with a "Buy" consensus rating and $8.6 price target (133.7% upside). 2 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ALVO price targets vary so much?
ALVO analyst price targets range from $5 to $10, a 58% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $8.6 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare